FIELD: organic chemistry, fungicides, pharmacy. SUBSTANCE: invention describes new azole compounds of the general formula (I) 
where values A, R1-R3, W, X, Y, Z, m are given in the p. 1 of the invention claim and can be used for treatment of patients with dermatomycosis, visceromycosis. Invention describes also a method of their synthesis, intermediate compounds and the pharmaceutical composition showing an antifungal activity. EFFECT: improved method of synthesis, enhanced effectiveness of compositions. 31 cl, 6 tbl, 165 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF ANTHRANILIC ACID OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS USED FOR THEIR SYNTHESIS AND DRUG | 1994 |
|
RU2128644C1 |
| DERIVATIVES OF TRIAZOLO[1,4]DIAZEPINE AND METHODS OF THEIR SYNTHESIS | 1989 |
|
RU2117670C1 |
| DERIVATIVE OF DI- AND TRIAZOLYLPROPANE, METHODS OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1996 |
|
RU2145605C1 |
| CONDENSED HETEROCYCLIC NITROGEN COMPOUNDS AND USING THEM AS INHIBITORS OF AMYLOID BETA PRODUCTION | 2010 |
|
RU2515976C2 |
| HETEROCYCLIC DERIVATIVES OF AMINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF CHOLINE ESTERASE ACTIVITY, METHOD OF SYNTHESIS OF COMPOUNDS | 1992 |
|
RU2119920C1 |
| DERIVATIVES OF CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUNDS AND METHOD OF THEIR SYNTHESIS | 1996 |
|
RU2167877C2 |
| CYCLOPROPANE COMPOUNDS | 2011 |
|
RU2571414C2 |
| CYNNAMIDE COMPOUND | 2005 |
|
RU2361872C2 |
| TRIAZOLE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND ANTIFUNGAL COMPOSITION | 1996 |
|
RU2146250C1 |
| 1,2,3,4-TETRAHYDROPYRAZOLO-[5,1-C]-(1,2,4)-TRIAZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION INHIBITING PRODUCING AN INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, METHOD OF PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PATIENTS WITH DISEASES MEDIATED BY INTERLEUKIN AND TUMOR NECROSIS FACTOR | 1994 |
|
RU2124517C1 |
